ACADIA Pharmaceuticals Inc. (ACAD) Tumbled -8.43% or -1.49 To Price $16.18 On Wednesday

ACADIA Pharmaceuticals Inc. (ACAD) tumbled -8.43% or -1.49 to $16.18. It is around 5.28 million shares traded, which is 248.93% compare to the average total volume 2.12 million. The market cap of ACAD is $2.02 billion. The year to date change is -885.13%. The 52 week price range is from $14.51 to $41.2. Price of ACAD have changed 0.86% during last week. It have changed -7.68% over last month, -31.75% over last 3 months, -39.44% over last 6 months and -34.75% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACAD is 18.26. It is 12.86% above current price. The 200-day Moving Averages for ACAD is 27.75. It is 71.51% above current price. The 52-week High is 41.2. It is 154.64% from the current price. The 52-week Low is 14.51. It is -10.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ACAD is 5.51 on 2018-05-31. Short % to float is 10.16%. There are some statistics of ACAD. It is has market cap $2.02 billion. The share outstanding is 124.83 million. The average volume is 2.12 million. The revenue is 66.05M. The gross profit is 61.69M. The percent of top 15 Institution holding is 96.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACAD is -67.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACAD is -59.92%.


Share this post